Rekah Pharmaceutical Industry Ltd. (TLV: REKA)

Market Cap	156.15M
Revenue (ttm)	331.60M
Net Income (ttm)	7.63M
Shares Out	11.41M
EPS (ttm)	0.68
PE Ratio	20.26
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	468
Average Volume	3,615
Open	1,388.00
Previous Close	1,388.00
Day's Range	1,380.00 - 1,401.00
52-Week Range	1,167.00 - 1,601.00
Beta	0.05
RSI	54.58
Earnings Date	Mar 27, 2025

About TLV: REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 427
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: REKA

Financial Performance

In 2023, REKA's revenue was 321.66 million, an increase of 10.01% compared to the previous year's 292.39 million. Losses were -6.91 million, 238.6% more than in 2022.